BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28741286)

  • 1. Interleukin 6 receptor (IL-6R) was an independent prognostic factor in cervical cancer.
    Luan S; An Z; Bi S; Chen L; Fan J
    Histol Histopathol; 2018 Mar; 33(3):269-276. PubMed ID: 28741286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer.
    Labovsky V; Martinez LM; Calcagno ML; Davies KM; García-Rivello H; Wernicke A; Feldman L; Giorello MB; Matas A; Borzone FR; Howard SC; Chasseing NA
    Tumour Biol; 2016 Oct; 37(10):13377-13384. PubMed ID: 27460086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of ROR2 is associated with unfavorable prognosis and tumor progression in cervical cancer.
    Sun B; Ye X; Lin L; Shen M; Jiang T
    Int J Clin Exp Pathol; 2015; 8(1):856-61. PubMed ID: 25755786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.
    Song Z; Lin Y; Ye X; Feng C; Lu Y; Yang G; Dong C
    Med Sci Monit; 2016 Nov; 22():4475-4481. PubMed ID: 27866212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
    Wang Y; Li D; Liu Y; Tian S; Chen X
    Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLNA is a predictor of chemoresistance and poor survival in cervical cancer.
    Jin YZ; Pei CZ; Wen LY
    Biomark Med; 2016 Jul; 10(7):711-9. PubMed ID: 27347840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.
    Li Y; Wu T; Zhang B; Yao Y; Yin G
    Med Oncol; 2012 Dec; 29(5):3394-9. PubMed ID: 22752570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.
    Guo L; Lu W; Zhang X; Luo D; Zhang H
    Int J Clin Exp Pathol; 2014; 7(7):4150-5. PubMed ID: 25120795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of AQP5 in cervical cancer: correlation with clinicopathological features and prognosis.
    Zhang T; Zhao C; Chen D; Zhou Z
    Med Oncol; 2012 Sep; 29(3):1998-2004. PubMed ID: 22048942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of flotillin-2 is associated with poor clinical survival in cervical carcinoma.
    Liu Y; Lin L; Huang Z; Ji B; Mei S; Lin Y; Shen Z
    Int J Clin Exp Pathol; 2015; 8(1):622-8. PubMed ID: 25755754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer.
    Jiang S; Wang HL; Yang J
    Int J Clin Exp Pathol; 2015; 8(1):806-11. PubMed ID: 25755778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.
    Hou T; Liang D; Yang D; He J; Huang Y; Zhang Y
    Int J Clin Exp Pathol; 2014; 7(3):1060-8. PubMed ID: 24695578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.